| | Laboratory investigations | | |
| | Blood | alanine-aminotransferase (AST) | 80 U/L (2 × ULN) | | aspartate-aminotransferase (ALT) | 103 U/L (>2.5 ULN) | | Total bilirubin | 1.8 mg/dL (normal < 1.2) | | lactic dehydrogenase (LDH) | 603 U/L (normal < 460) | | HIV-Ab (including RIBA) | Positive | | CD4+ cell count and % | 710/mL; 45% | | CD8+ cell count and % | 595/mL; 37% | | CD4+/CD8+ ratio | 1.2 | | HIV viral load | 4,400 copies of HIV-RNA/mL | | Hepatitis B virus markers | HBs-Ab, total HBcAb, and HBeAb: positive | | haemochrome, C-reactive protein, blood sugar, uraemia, creatinine, γ-glutamiltranspeptidase, alkaline phosphatase, creatine-phosphokinase, amylase, lipase, triglycerids, ions, protidogram, immunoglobulins (total IgG, IgM, IgA), Hepatitis C Virus-Ab, coagulation tests, complement fractions (C3 and C4), ANA, syphilis tests (TPHA and RPR), and urine analysis | Negative or within normal ranges | | Cerebrospinal fluid | Cells | 3/mL (all mononuclear cells) | | Proteins | 291 mg/dL | | Protein analysis | Barrier damage with proportional increase in IgG and albumin | | HIV viral load | Not detectable | | Glucose, oligoclonal IgG bands, culture for bacteria and fungi, and syphilis tests (TPHA and RPR) | Negative or within normal ranges |
|
|
